Charlie Shreve

Charlie is a Principal at Shore Capital, a lower middle-market private equity firm focused on partnering with companies that have between $1-10 million of EBITDA. Charlie’s responsibilities include sourcing, evaluating, and enabling the growth of Shore investments in the healthcare industry. Charlie is a Director for Innovate 32 and is closely involved with SENTA, OMS360, and Triumph Orthopedics.

 

Previously, Charlie led business development and strategy at Shore’s ophthalmology-focused portfolio company, EyeSouth Partners. At EyeSouth, Charlie oversaw the growth efforts which expanded the network to encompass 25+ practices, 210+ physicians, and 115+ clinical and surgical locations. In addition, Charlie formerly worked at Keystone Capital as an investment professional and Jefferies as an investment banker.

 

Charlie received a B.S. in Finance from the University of Kansas